April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
Evaluation of Factors Affecting Corneal Permeability for Congeneric Drugs Using Cassette Dosing Technique: An Approach for Preclinical Ophthalmic Drug Discovery
Author Affiliations & Notes
  • C. Sharma, IV
    Molecular Dynamics Lab.,
    All India Institute of Medical Sciences, Delhi, India
  • T. Velpandian
    All India Institute of Medical Sciences, Delhi, India
  • N. R. Biswas
    All India Institute of Medical Sciences, Delhi, India
  • R. B. Vajpayee
    All India Institute of Medical Sciences, Delhi, India
  • N. Nayak
    All India Institute of Medical Sciences, Delhi, India
  • S. Ghose
    All India Institute of Medical Sciences, Delhi, India
  • Footnotes
    Commercial Relationships  C. Sharma, IV, None; T. Velpandian, None; N.R. Biswas, None; R.B. Vajpayee, None; N. Nayak, None; S. Ghose, None.
  • Footnotes
    Support  We acknowledge Prof.Jayaram, IITDelhi for insilico designing, CSIR for SRF and AIIMS intramural grant
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 2445. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      C. Sharma, IV, T. Velpandian, N. R. Biswas, R. B. Vajpayee, N. Nayak, S. Ghose; Evaluation of Factors Affecting Corneal Permeability for Congeneric Drugs Using Cassette Dosing Technique: An Approach for Preclinical Ophthalmic Drug Discovery. Invest. Ophthalmol. Vis. Sci. 2010;51(13):2445.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Cassette dosing (N-in-One) is high throughput pharmacokinetic technique. The study evaluated various factors affecting corneal permeability for topically applied congeneric drugs using this technique. Further, a novel QSPR based insilico model was developed to predict corneal permeability using fluoroquinolones as model group.

Methods: : Sterile cocktail formulations for topically used nine fluoroquinolones (ciprofloxacin, norfloxacin, ofloxacin, pefloxacin, lomefloxacin, levofloxacin, sparfloxacin, gatifloxacin and moxifloxacin) were prepared using cassette dosing technique. Cocktail formulations were prepared at three different concentrations (0.025,0.5&0.1%), further each formulation was adjusted three pH range (4.5,7&8). Each sterile formulation was instilled into rabbit cornea (n=4eyes) at different volumes (12.5,25&50µl). Aqueous humor was aspirated at various intervals through paracentesis after topical anesthesia. All the biosamples were analyzed using LC/MS-MS to determine corneal permeability for each fluoroquinolone. Further, a novel insilico model was developed to predict corneal permeability of topically applied drugs. Various molecular descriptors (n=72) were derived for all fluoroquinolones using different softwares. The applicability of previously reported models to predict corneal permeability for fluoroquinolones was also evaluated.

Results: : Various pharmacokinetic parameters like Cmax, Tmax, AUC, Papp were derived all fluoroquinolone using cassette dosing technique. Factors like concentration, pH and volume of instillation of formulation showed pronounced effect on transcorneal permeation. Previously, reported insilico models based upon molecular descriptors like ΔlogP, charge or molecular volume were unable to predict transcorneal penetration of fluoroquinolones. Therefore, a novel QSPR based model was generated using molecular descriptors like logP, pKa, with either GAP or PSA which predicted better corneal permeability as compared to reported models (r=0.940).

Conclusions: : Cassette dosing can be well exploited in ophthalmic drug discovery to study pharmacokinetic profile. Various factors have profound affect on corneal permeability of topically applied drugs. The newly developed QSPR model showed better predictability as compared to reported models.

Keywords: cornea: basic science • computational modeling • antibiotics/antifungals/antiparasitics 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×